MyFinsight
Home
Blog
About
Net loss
-$3,366,082
(17.11%↑ Y/Y)
Health Care Patient
Service
$1,244,142
Histology Service Fees
$248,260
Medical Director Fees
$17,544
Other Revenues
$633
Net loss before
provision for income tax...
-$3,366,082
(16.51%↑ Y/Y)
Laboratory Services
$1,510,579
Loss from operations
-$3,334,864
(-32.57%↓ Y/Y)
Total other income
(expense), net
-$31,218
(97.94%↑ Y/Y)
Net revenue
$1,510,579
(18.99%↑ Y/Y)
Other income
$4,738
(-87.55%↓ Y/Y)
Interest income
$3,358
(65.83%↑ Y/Y)
Total operating
expenses
$4,845,443
(28.02%↑ Y/Y)
Other expense
$27,626
(-94.28%↓ Y/Y)
Interest expense
$11,688
(11.74%↑ Y/Y)
Selling, general and
administrative
$2,858,590
(29.08%↑ Y/Y)
Direct costs and
expenses
$1,087,837
(7.01%↑ Y/Y)
Clinical development
$475,885
(268.11%↑ Y/Y)
Research and development
$361,575
(16.12%↑ Y/Y)
Depreciation and
amortization
$61,556
(-45.64%↓ Y/Y)
Back
Back
Income Statement
bioAffinity Technologies, Inc. (BIAFW)
bioAffinity Technologies, Inc. (BIAFW)
source: myfinsight.com